Drug profile · INN
enalapril maleate
AQUMELDI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
enalapril maleate (AQUMELDI) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN enalapril maleate
Brand AQUMELDI
Route ORAL
Formulation TABLET, EXTENDED RELEASE
ATC code C09AA02
Originator Amneal Pharma Europe Ltd
Frequently asked questions
What is enalapril maleate?
enalapril maleate (AQUMELDI) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for enalapril maleate?
AQUMELDI is a marketed brand name for enalapril maleate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of enalapril maleate?
enalapril maleate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.